Albert David Limited (NSE:ALBERTDAVD)

Market Cap	4.61B
Revenue (ttm)	3.27B
Net Income (ttm)	62.94M
Shares Out	n/a
EPS (ttm)	11.03
PE Ratio	73.27
Forward PE	n/a
Dividend	5.00 (0.62%)
Ex-Dividend Date	Jul 25, 2025

Volume	2,046
Average Volume	2,682
Open	812.85
Previous Close	803.25
Day's Range	801.00 - 812.85
52-Week Range	762.60 - 1,565.00
Beta	0.06
RSI	41.46
Earnings Date	Nov 11, 2025

About Albert David

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1938
• Employees: 1,805
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ALBERTDAVD

Financial Performance

In 2024, Albert David's revenue was 3.46 billion, a decrease of -4.61% compared to the previous year's 3.62 billion. Earnings were 172.01 million, a decrease of -77.19%.